Likewise, ornithine decarboxylase launches the polyamine biosynthetic pathway by using ornithine, and is activated with high expression in cancer cells to increase the susceptibility of tumor development to changes in polyamine levels and by transforming the response to cytokines, abnormal oncogenic gene expression, and tumor promoter mutations [80,81]. This evidence concerns the gene ODC1 and cancer.